Search

everythinglearnresearchcommunity

for

Search:↓

Most patients with telogen effluvium had low iron and vitamin D levels; iron supplements were commonly prescribed.

COVID-19 patients may experience hair loss, but it's not linked to their age or sex.

Poor sleep during the pandemic may increase stress and worsen hair loss conditions.

A woman experienced temporary hair loss after taking albendazole, which resolved on its own within 3 months.

Hair loss can be an early sign of HIV infection.

The herbal extract was found to effectively reduce and prevent hair loss without any side effects.

Hair loss from telogen effluvium may not happen again after another surgery.

COVID-19-related hair loss may have unique features compared to hair loss from other causes.

Hair loss from telogen effluvium can cause mental health issues and lower life quality, needing both medical and emotional support.

A woman lost over 80% of her hair due to a condition called telogen effluvium after having COVID-19.

Trichodynia found in 29% of TE or AGA patients, linked to psychological conditions.

Dengue fever can cause a temporary type of hair loss called telogen effluvium.

Proteoglycans are important for hair growth, and a specific treatment can help reduce hair loss.

Albendazole may cause hair loss.

A woman had hair loss, nail changes, and skin peeling after a COVID-19 infection, which got better on their own.

Miliacin with polar lipids helps hair growth and improves hair loss in women.

Trichobiolight effectively treats hair loss with 82.5% success.

RV3466F lotion significantly reduces hair loss and improves acute telogen effluvium.

The tincture made from nettle, sage, and horse chestnut in a 5:3:2 ratio is effective for treating telogen effluvium.

Vitamin D deficiency is common in temporary hair loss, and stress is often a suspected cause.

Telogen effluvium is a common hair loss condition where many hairs enter the resting phase, often not noticeable until significant loss occurs, and treatment focuses on the underlying cause.

Oxidative stress is likely important in causing telogen effluvium, and antioxidants might help treat it.

The document concludes that we need more research to understand Telogen Effluvium and find effective treatments.

Platelet-rich plasma is a promising and safe treatment for increasing hair density and thickness in women with chronic telogen effluvium.

Some people in Saudi Arabia experienced hair loss after the COVID-19 vaccine, more often in women and those without prior hair loss.

A new treatment using stem cell-conditioned media significantly improved hair growth in people with temporary hair loss.

Low levels of iron and vitamin D might be linked to chronic hair loss in women.

Monocytes might be linked to hair loss after COVID-19.

The hair lotion reduced hair loss and sped up recovery in women with acute telogen effluvium.

Telogen effluvium increased globally after COVID-19, especially in Asian and Latin regions.